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Extracting DNA from samples and creating a NGS library for metagenomics samples is a 
modern way of studying the genetic diversity within organisms and environments. Although 
the theoretical and practical details of these methods are well known, there is no single, 
standardized way to perform such a study. 
 
The purpose of this thesis was to create an NGS DNA metagenomics library for a Parkin-
son’s disease study. This thesis explains the theory behind the process and contemplates 
on the possible improvements that could be made to the laboratory protocols. 
 
The thesis project started by extracting stool DNA, after which the NGS library was created 
and analysed. Concentration values gained from DNA extractions, PCR and Illumina se-
quencing were documented and reviewed in the results section of this thesis. 
  
The DNA extraction concentration values were distributed normally when looked at statisti-
cally. From 138 samples, only one failed to produce any results due to a small amount of 
DNA during the extractions. The Illumina reads obtained were suitable for further analysis, 
although the quality of the reads could have been better. 
 
By studying the results, it can be concluded that the creation of the DNA metagenomics 
library was a success although some of the samples in the pool were present in greater 
proportions than others. The standard deviation for all reads was ≈ ± 3 611 000 reads, and 
the average was ≈ 5 055 000 reads. 
Keywords Parkinson’s disease, metagenomics, DNA library, Illumina, 
sequencing, stool, DNA extraction, DNA 
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DNA:n eristäminen ja NGS metagenomiikkakirjaston luominen on moderni tapa tutkia 
geneettisen materiaalin monimuotoisuutta ympäristönäytteissä sekä kudosnäytteissä. 
Vaikka näiden menetelmien teoria ja käytäntö ovat yleisesti ottaen selvitettyjä, ei 
kokonaisprosessille ole yhtä ja oikeata tapaa suorittaa. 
 
Opinnäytetyön tavoite oli luoda metagenomisia DNA kirjastoja osana Parkinsonin taudin 
tutkimusta. Tekstissä käsitellään myös menetelmiin pohjautuvaa teoriaa ja pohditaan 
mahdollisia parannuksia, joita niihin voisi soveltaa. 
 
Työ aloitettiin eristämällä ja puhdistamalla ulostenäytteiden DNA, jonka jälkeen niistä 
muokattiin DNA kirjasto, joka analysoitiin Illuminan sekvensaattorilla. DNA eristyksistä sekä 
PCR ja Illumina ajoista saadut arvot kirjattiin ylös ja niitä tarkastellaan tämän opinnäytetyön 
tuloksissa. 
 
Näytteiden eristyksien pitoisuudet olivat normaalijakautuneita. 138 näytteestä ainoastaan 
yksi ei tuottanut tulosta vähäisen DNA määränsä takia. Illuminan sekvensointi onnistui, 
vaikkakin sekvensoinnin laatu olisi voinut olla parempi. 
 
Tuloksista voitiin päätellä, että metagenomisen DNA kirjaston luominen onnistui, vaikkakin 
jotkin näytteistä tuottivat enemmän sekvenssejä kuin toiset. Illumina ajon keskihajonta 
kaikille näytteille oli ≈ ± 3 611 000 sekvenssilukua ja keskiarvo ≈ 5 055 000 sekvenssilukua. 
Avainsanat Parkinsonin tauti, metagenominen, DNA kirjasto, Illumina, 
sekvensointi, uloste, DNA:n eristäminen, DNA 
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IBS Irritable bowel syndrome 
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AATI Advanced analytical technologies Inc. 
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1 Introduction 
 
This thesis is based on previous findings which suggest that there is an association be-
tween certain gut bacteria and the Parkinson’s disease. The Thesis is part of a meta-
genomics study conducted by the DNA sequencing and genomics laboratory at Institute 
of Biotechnology of Helsinki University. 
 
The purpose of this thesis was to create a metagenomics DNA library from PD stool 
samples for the Parkinson’s disease study, and to describe in theory and practice the 
methods used when creating a metagenomics library. In addition, some of the working 
methods and their effects on the DNA products have been reviewed through scientific 
literature and personal observations. Metagenomics studies the genetic material found 
in an environment or in other genetically complex systems. 
 
The protocols and other methods used during the laboratory work were either provided 
by the laboratory staff or came with the kits and they can be found in the appendix. 
 
2 Parkinson’s disease 
 
Parkinson’s disease is a slowly proceeding movement disorder typically diagnosed be-
tween ages 50 to 70. The difficulties in movement are caused by the loss of dopaminergic 
neurons in the substantia nigra. The effects of the disease are better described in Figure 
1. Even though scientists have managed to connect Parkinson’s disease with genetic 
changes, environmental factors and heredity, the major cause for losing the dopaminer-
gic neurons remains unknown [1, 2]. This could be one of the reasons why non-motor 
symptoms of the Parkinson’s disease are increasingly more studied. 
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Figure 1. Figure on the left shows the differences in brain structure between a healthy person 
and a person who suffers from Parkinson’s disease [3]. Figure on the right is a sketch 
of a person who has Parkinson’s. It depicts the poor posture, slowed movements and 
tremor contained by pinching the fingers together [4]. 
 
2.1 Connection with gut microbiota  
 
Only recently has the correlation between gut microbiota and the central nervous system 
been studied. These studies have found that gut microbiota could play a major role in 
how certain disorders such as IBS, depression, anxiety and chronic pain form, all of 
which have relations to the CNS. In nature, there are even some examples where small 
parasites have taken control over the entire nervous system of a simple organism [5]. 
 
 
 
Figure 2. Parasitic fungi, ophiocordyceps unilateralis, infested dead ant. The fungi controls the 
ant and forces it to move into higher grounds. There it makes the ant to strike its jaws 
deep into a plant and remain there until dead [6]. 
3 
 
 
2.1.1 Previous research 
 
Many observations have concluded that gastrointestinal dysfunction is common in Par-
kinson’s disease. As a non-motor feature, this connection has not been studied as much 
as the primary symptoms of Parkinson’s, even though the interaction between the gut 
and the central nervous system has been suggested to exist before [7]. 
 
Bulding on these previous studies, researchers [8] have found a connection between the 
gut microbiota and Parkinson’s disease. In the study, gut microbiota of 72 PD- and 72 
control patients were compared through high-throughput sequencing of 16S rRNA genes 
for phylogenetic marker analysis. The results suggest that the patients who have Parkin-
son’s, tend to lack at least one family of bacteria that is commonly present in control 
subjects, and that some of the motor phenotypes could be related to the abundances of 
specific bacterial species within the gut [8]. 
 
3 Researching the gut microbiota from stool samples 
 
The gut microbiota varies with the hosts genetic background, living environment and 
lifestyle. These micro-organisms work in a symbiotic way within the intestinal track of the 
host, which is beneficial for the host and the microorganism [9]. They are a part of the so 
called normal flora which includes all of the symbiotic micro-organisms in the human 
body.  
 
Human stool is ideal for metagenomics study since it consists of as [9] describes, “nearly 
200 prevalent bacterial species and approximately 1000 uncommon species”. It is also 
a good way to study human diseases since every person, sick or healthy, produces it, 
and since it contains so much information on how the human body is functioning. 
 
3.1 Metagenomics 
 
Metagenomics, also known as environmental genomics, studies the genetic material 
found in an environment. Rather than researching a single microbe, it involves studying 
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the whole community of microbes found for example in water, soil or stool. The method 
is to extract the whole community DNA from an environmental sample, purify it and cre-
ate a DNA library from it. The libraries are then used to study the variations in microbial 
communities or to study the genomic structures of individual species [10]. 
 
 
 
Figure 3. A protocol for executing a metagenomics study [11]. 
 
As [9] describes, gut microbiota can be studied in different ways such as descriptive 
metagenomics and functional metagenomics. The first concentrates on studying the 
community’s structure, microbial variation and amount. The latter concentrates on stud-
ying the interactions between host/microbe and microbe/microbe functions. 
 
Many microbes cannot be cultured under standard laboratory conditions. Even if they 
could be cultured, studying the interactions between all the micro-organisms would be 
impossible due to the technical constraints involved and the time consumed during the 
process. This is why the metagenomics approach works better when studying complex 
relations between microbes. 
 
The metagenomics approach has been successful in generating large numbers of met-
agenomics sequence datasets that help us to understand the functions and relations of 
gut microbiota better [9]. 
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3.2 Processes 
 
Collecting a stool sample is fairly easy due to the abundance and composition of the 
sample material. However, the sample handling protocols vary depending on the study. 
For example a medical stool sample might require a certain diet before sampling and 
has to be delivered to medical staff within days of the collection [12], whereas with met-
agenomics samples the diet is normal, stool is homogenized in a preserving buffer and 
can be stored in a freezer for days or months before actually being studied. [13] 
 
Sampling, storing and processing has been found to have an effect on the results of DNA 
sequencing [14, 15]. For example, in a study conducted by [14], a stool sample that had 
been left in room temperature for 2 weeks before freezing it at -80 °C had lost nearly all 
high-molecular weight fragments. This type of fragmenting also occurred while unfreez-
ing the samples from -20 °C in 1 h prior to freezing them again in -80 °C. The best con-
ditions for high-molecular weight fragments were when the sample was frozen immedi-
ately after sampling in -20 °C and then transferred to -80 °C, or when the samples were 
kept in room temperature after sampling for 3 h before freezing at -80 °C [14]. Although 
storage conditions prior to DNA isolation might affect the DNA fragment size, they do not 
affect the variation of bacterial species significantly unless the sample has been left in 
room temperature for a time period of 2 weeks or more prior to freezing. The thawing of 
the samples at the beginning of the DNA extractions has an impact on the taxonomic 
composition of the samples at the genus and species level [14]. 
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Table1. [14] Changes in the composition of the bacterial taxa in the studied stool samples. The 
values on the table represent the percentage of each major taxon out of the total num-
ber of sequences. 
 
 
 
Table 1 shows that the samples that had been unfrozen before the extractions for a 
longer time, had differences between their major bacterial taxa. 
 
 
 
Figure 4.  “The % change in bacterial community composition in the stool samples compared to 
samples frozen immediately. Each point is the mean of samples from four individuals 
with the bars representing the standard error about the mean.” [15] 
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Figure 4 shows that if the samples are not frozen immediately after the sampling, their 
bacterial community composition will change gradually, the more time it stays in a room 
temperature. 
 
3.2.1 DNA extraction 
 
DNA extraction is a crucial step when studying the gut microbiota since it has a direct 
effect on the outcome of the downstream analysis. There are many ready to go protocols 
for extracting the DNA. Choosing the right protocol is essential since choosing the wrong 
method could have a great impact on the purity and amount of the DNA gained. A higher 
yield and a better quality of DNA will give more accurate results [16, 17]. Many of the 
protocols, if not all, follow the same principle: break the cell wall and liberate the DNA, 
remove PCR inhibitors and proteins and elute the DNA. 
 
Stool sample cell lysis, as described by [16], can be done either mechanically, chemically 
or enzymatically. Mechanical bead lysing is one of the most efficient ways of cell lysing 
since it not only breaks the cell wall but homogenizes the sample even further. The lysing 
and homogenization effect of the beads give the reagents in the next step an ideal envi-
ronment for removing PCR inhibitors from the sample. Although bead lysis provides an 
efficient way of exposing the DNA, it is considered to be too destructive for chromosomal 
DNA studies [16]. 
 
Stool samples contain many inhibitors that consist mostly of bile salts and complex pol-
ysaccharides [18, 19]. Bile salts are conjugated bile acids and form approximately 0.7 % 
of the total bile secreted from the liver. If not removed properly from the sample, they can 
inhibit the functioning of DNA polymerase or other reagents, depending on cofactors, in 
the PCR reaction. [18] Complex polysaccharides, at least in plant DNA preparations, can 
contaminate and inhibit both the restriction enzyme treatments and the PCR [19]. The 
removal of these inhibitors is done with bile salt binding chemicals. Shown by [20], bile 
salts can be inhibited by binding them to molecules such as cholestyramine, meciadanol, 
sucralfate or aluminium hydroxide and magnesium hydroxide [20]. Since the binding re-
moves most of the inhibitors from the samples, the remaining inhibitors can be removed 
through a simple washing step. For example, in [21] a silica membrane type of DNA 
binding and washing step reduced the amount of PCR inhibitors from 12.5 % to 1.1 %. 
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Commonly, the removal of inhibitors is done by binding the DNA molecule into another 
molecule and washing its surroundings or by pelleting the inhibitors via centrifugation 
step and removing the supernatant. 
 
 
 
Figure 5. Inhibitor inhibiting the functioning of an enzyme at the top. Enzyme helping in the pro-
duction of a molecule at the bottom [22]. 
 
Stool samples contain many proteins that need to be removed since excess amounts of 
protein can inhibit the PCR or damage the DNA. One of the most commonly used pro-
teinases is proteinase K. As described by the manual [23], it cleaves peptide bonds at 
the carboxylic sides of aliphatic, aromatic or hydrophobic amino acids. In [24] it was ob-
served that proteinase K together with dodecylsulfate would provide complete protection 
from ribonuclease to the tested polysomal RNA. It was also noted that in addition to 
dodecylsulfate, urea stimulates the activity of proteinase K as well. In [24] the sample 
that had been treated with only proteinase k, liberated only 7 % of the total amount of 
aromatic aminoacids, whereas, with dodecylsulfate it was as high as 93 %. Many of the 
manufacturers take this factor into account and for example [23] manual says “The ac-
tivity of the enzyme is stimulated by 0.2 - 1 % SDS or by 1 - 4 M urea” [23, 24]. 
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Figure 6.  An example of the chemical reaction for the activity of proteinase K on polypeptides 
[25]. 
 
The washing and elution steps are the final steps when processing the DNA. Washing 
step purifies the DNA from most of the remaining contaminant proteins and PCR inhibi-
tors. The washing step can be performed, for example, with the help of a silicate filter. 
Silicate binds to the DNA in the presence of strong salts. This is possible due to the 
negative charge of both, DNA and silica. The positively charged ionised salt molecules 
set between these negative charges and form a hydrogen bond. This bond will not break 
as long as the amount of salt stays high and pH stays stable. This allows for the DNA to 
be washed with salts and ethanol, removing impurities even further from the sample [26]. 
However, a study conducted by [16] notes that the efficiency of the DNA binding with 
silica based elution can be as little as 21 % of the initial amount of DNA. 
 
 
 
Figure 7. Principle behind the silicate membrane binding of the DNA. In the presence of cha-
otropic salt, the DNA molecule binds to the hydrolysed Na+  with hydrogen bonds [27]. 
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The DNA, bound on the silicate filter, is eluted when the concentration of the binding salt 
is diluted enough. The dilutant is called elution buffer and is a substance designed for 
storing the samples and the elution of DNA. The DNA is eluted through the filter with a 
centrifuge. 
 
3.2.2 DNA sequencing library 
 
A DNA sequencing library consists of fragments of DNA that represent the genetic diver-
sity of the environment or a single organism. The creation of these libraries can vary 
since there are different protocols for cDNA libraries and DNA libraries. The principle 
behind the workflow is: fragment the DNA, size select the appropriate fragments, repair 
the ends of the fragments, attach adapters and amplify the fragments with PCR [28]. 
 
Fragmenting the DNA can be done enzymatically, chemically or mechanically. Mechan-
ical fragmentation can be done acoustically by concentrating highly dense soundwaves 
at the DNA, to break the structure vertically. The breaking is done by cavitation bubbles 
formed by the soundwaves. Cavitation bubbles are formed when soundwaves separate 
and form a gap in between the water molecules. The gap absorbs energy until it implodes 
and shears anything around it. The efficiency of the fragmentation depends on the purity 
of the DNA, the fragmentation on / off time, the concentration of the sample, temperature 
and purity of the water, the intensity of the soundwaves etc. [28, 29]. The cavitation pro-
cess is depicted in Figure 8. The length of the resulting DNA fragments is determined by 
the wanted library size and the limitations of the sequencing equipment [28].  
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Figure 8. Sonication forms cavitation bubbles that implode and damage the surrounding DNA 
and other material [29]. 
 
The fragmentation of the dsDNA creates fragments that can be partially double stranded 
(ds) and partially single stranded (ss). This type of broken DNA is not compatible with 
the adapter ligation step and will cause an insufficient library dataset for the extracted 
samples. The ends of the fragments are repaired by using several DNA building rea-
gents: T4 polynucleotide kinase, T4 DNA polymerase, Taq DNA polymerase, BSA, ATP 
and dNTP. In this process, ATP and dNTP work as building blocks for the DNA synthesis 
[Appendix 4, Norppa-library protocol]. 
 
T4 DNA polymerase catalyses 5’ → 3’ nucleotide synthesis on a DNA template. It also 
has 3’ → 5’ exonuclease activity which removes the hanging nucleotides from the 3’ end. 
These qualities produce blunt dsDNA strands. BSA works to stabilize the exonuclease 
activity of the T4 DNA polymerase. At the same time it also inactivates the contaminating 
nucleases and proteases and prevents the DNA from binding on the sides of the testing 
tube, keeping the reagents separated from the wall [30-32]. At the same time as the T4 
DNA polymerase repairs or cleaves the strands at 5’ or 3’ end, the T4 polynucleotide 
kinase catalyses a transfer reaction of phosphate from ATP to the 5’ end of the DNA 
strand. T4 polynucleotide kinase also works as 3’ phosphatase, preventing the addition 
of more nucleobases at the 3’ end of the fragments. The phosphorylation modification 
allows for the DNA to be ligated later with another nucleotide sequence [33]. Since the 
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T4 DNA polymerase works as 3’ → 5’ exonuclease for ssDNA and dsDNA, it needs to 
be inactivated. Both of the T4 enzymes are inactivated by placing the samples in 75 °C 
for 10 min. During the inactivation, it is probable that the DNA fragments will sustain 
some damage done by the T4 DNA polymerase at the 3’ ends. If the strands get dam-
aged, they are repaired in 5’ → 3’ direction by the Taq DNA polymerase which stays 
active on high temperatures. The correct function of the Taq DNA polymerase in this 
reaction however is to add an A-overhang onto the 3’ end of the DNA fragment. The end 
repair product is a double stranded, blunt ended, 5’ phosphorylated and 3’ A-tailed DNA 
fragment [Appendix 4, Norppa-library protocol], [30, 32-36]. 
 
 
 
Figure 9. End repair process explained on the molecular level. The effect of two enzymes on 
the DNA fragments in the presence of ATP, dNTP, BSA and the reaction buffers. 
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Figure 10. The function of Taq DNA Polymerase enzyme on the DNA fragment in the presence 
of ATP, dNTP, BSA and the reaction buffers during end repair process. 
 
For the sequencer to be able to differentiate the fragmented sequences from each other, 
the fragments need to be labelled. The first step is to ligate an adapter to the phosphor-
ylated and A-tailed fragments. The adapter consists of dsDNA with a blunt end and a 
sticky end. The blunt end will be ligated with phosphorylated and A-tailed dsDNA, and 
the sticky part will be ligated with label. T4 DNA ligase catalyses this reaction and unites 
the blunt dsDNA with the blunt part of the adapter. In addition, it also ligates missing 
nucleobases onto the DNA strand if provided with additional dNTPs. After the adapter 
ligation, the DNA is ready for the PCR and the adding of indexes [37] [Appendix 4, Nor-
ppa-library protocol]. 
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Figure 11. An example of the Adapter ligation reaction with T4 DNA ligase. At the top, the Y. 
adapter is on the right and the product from the end repair is on the left.  
 
The DNA index complex consists of a primer, n amount of bp indexes and a universal 
complementary sequence used by the Illumina sequencer. During the PCR, the comple-
mentary primer binding site of the DNA index complex will attach to the complementary 
adapter primer binding site B. The DNA polymerase then copies the strand once. After 
the first copy, another primer, consisting of the primer and a universal sequence, at-
taches itself to the adapter primer binding site cA. The DNA strand is now attached with 
both primers and will copy itself for additional rounds of PCR cycles. The final product 
consists of the primers, index bp and universal sequences and the insert [38] [Appendix 
4, Norppa-library protocol]. 
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Figure 12. Binding of the index primers into a Y- adapter ligated DNA insert. For Illumina reads 
there are also two individual universal sequences ligated at the end of both primers 
next to the indexes with names U- strand A, UA and U-strand B, UB. 
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3.2.3 Illumina sequencing 
 
The final library will be analysed with a sequencing machine. For Illumina machines, the 
protocol is such: the library is clustered, amplified and analysed in three or four sessions 
of DNA synthesis. The sample attaches to the bottom of the flow cell which has comple-
mentary universal sequences attached on it. First the forward sequence is read, then the 
index sequence and then the reverse sequence. If there are two indexes, there will be 
an additional read between the second and the third read. 
 
In clustering, DNA strands are copied isothermally through bridge amplification. The in-
dividually marked DNA fragments have two universal sequences attached that are com-
plementary to the probes attached on the Illumina flow cells. The DNA fragment bends 
on the flow cell and forms a bridge with the other complementary probe. The DNA strand 
is then copied while attached to both probes. When denatured, it leaves us with two 
copies of the DNA strands that are then amplified in the same method prior to the reads 
[39]. 
 
 
 
Figure 13. The bridge amplification done by the Illumina machine. The probes are attached to the 
bottom. DNA strands attach and build up on these probes [40]. 
 
Reverse strands are washed, leaving the forward strands on the flow cells. Sequencing 
primer is then added, followed by the adding of fluorescent marked nucleotides. The 
clusters are bombarded with a light source that reacts every time a new complementary 
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nucleotide is added to the DNA strand. Fluorescent marked nucleotides have a termi-
nated 3’ end which means that they lack the 3’ OH group needed for the adding of the 
next base. The next nucleotide can be added after the OH group has been attached to 
the terminated nucleotide. Unattached nucleotides are washed from the flowcell before 
the adding of OH group. For this reason fluorescent marked terminated nucleotides get 
added one by one to the DNA strand. When bound to the strand, they emit an individual 
light signal that is registered on the sequencer thus giving the order of the complimentary 
nucleotides on the DNA strand. The registered base is determined by the average of all 
strands in the cluster. The more strands there are amplified within the cluster, the more 
accurate the signal becomes. After the insert has been read, another sequencing primer 
is attached to the index primer and the fluorescent nucleotides are analysed. After this, 
the DNA strand is bent again to form a bridge with the reverse probe. The ssDNA strand 
is then copied, denatured and the forward strand washed away. Reverse strand is then 
read with the same principle as the forward strand [39]. 
 
3.3 Contamination 
 
When dealing with samples that are going to be processed with PCR, it is important to 
understand all the sources of possible contaminants. As the research on intensive care 
unit bacterial communities [41] shows, even the places deemed to be most clean may 
contain a complex bacterial community. In addition, other studies prove that microbial 
activity can occur even in altitudes as high as the upper troposphere 15 km [42]. So if 
microbes can rise to altitudes as high as this, they surely have no trouble reaching the 3 
m altitudes represented by a common laboratory. As [43] shows, contaminating microbes 
can also be found within reagents. This is especially difficult when dealing with samples 
that have a low amount of DNA [41-43]. 
 
The spreading of bacteria through surfaces and room air is noted in today’s laboratories 
by using aseptic techniques. All the handling of the reagents and samples can be done 
inside a laminar which filters the air very clean. In addition, the laminar can be cleaned 
with 80 % ethanol after every task. Combined with the use of proper laboratory equip-
ment such as laboratory jacket, rubber gloves, sterile pipet heads and tubes, many of 
the contaminants can be countered. 
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3.4 Batch effects 
 
During a metagenomics study, a large number of samples are processed. Most of the 
time these samples arrive to laboratories in batches. Because of tight schedules within 
the laboratories, these batches are commonly processed separately. For assessing the 
working methods, the order in which samples are handled, has to be randomised. Ran-
domization is done to minimize the so called batch effects.  
 
Batch effects are caused by unknown technical variables present in the study. Such a 
variable can have an effect on the results and distort them. The distorting variable can 
be from simple source, such as damaged laboratory equipment, or as complex as a 
variable created by the combined effect of ten other variables [44]. These combined var-
iables are common in biological studies where multiple reagents and conditions are pre-
sent. 
 
Batch effects have been studied for a long time through various standardised mathemat-
ical methods such as the ANOVA tests. Studying the results enable us to specify the 
distorting variables and to narrow down the possible contaminants. These types of stud-
ies are also crucial when optimizing laboratory methods.  
 
4 DNA extractions of PD stool samples 
 
Gut microbiota DNA extractions were done to 138 samples and X lambda DNA controls. 
The extractions were done in 2 batches, first with 119 samples and the second with 19 
samples. 11 extractions were repeated due to low amounts of DNA. The first batch was 
done 17.3 - 2.4 and the second batch 29.4 - 4.5. The average amount of DNA extractions 
done daily was 10 samples, starting with 2 and 5 samples and finishing up with 15 sam-
ples a day. The stool samples were collected from Parkinson’s disease patients, their 
spouses and control patients in Finland. Samples were stored in PSP kit’s buffer after 
sampling, frozen and shipped to the laboratory in dry ice. They were then moved into a 
-80 °C freezer to await for the extractions [13]. 
 
Most of the stool samples were processed accordingly to the same protocol during the 
stool extractions. Only one of them, P_41, failed to give a sufficient amount of DNA for 
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making a library. The protocol for the extractions was carried out accordingly to the pro-
tocol depicted in the appendix [Appendix 5, PSP spin stool DNA plus kit protocol]. 
 
4.1 Extraction order and thawing of the samples 
 
The extraction order for the samples was determined by randomizing the previous listing 
order of the samples with an excel function. The correct samples could be picked with 
the help of the box coordinates sheet provided by the sampling laboratory. Samples were 
then moved into a laminar in a room temperature and thawed. The thawing usually took 
approximately 1 h. 
 
Most of the times the samples would thaw equally. Some samples, however, would melt 
more rapidly than others. This type of unequal melting would happen each time the sam-
ples were thawed. Though as [14] and [15] suggests, there is no significant additional 
damage done to the DNA fragments or variation of bacterial species, unless the samples 
would be kept melted for extra hours or days. 
 
4.2 Sample homogenization and prelysis 
 
After thawing, each sample was transferred into a 2.0 ml safe lock tube. This would be 
done in 2 portions. First portion would take 1.0 ml and the second 0.4 ml of sample. The 
samples were then moved into a thermomixer to maximize the amount of bacterial DNA. 
Meanwhile the laminar was cleaned and the stool moved back into the freezer. After the 
thermomixer, 5 zirconia beads were added manually to each sample tube and the tubes 
were vortexed, two at a time, with a table vortex for 2 minutes. After this, the solids were 
pelleted with a centrifuge. 
 
The order of the sampling would be determined by the order in which the samples were 
taken from the freezer. Since some of the samples would have solid stool in them, it was 
better to take 1.0 ml first to ensure that there was enough of the sample for the next 
steps. Adding the zirconia beads manually was sometimes difficult since they would drop 
from the tubes in clusters. It would also take some time to get used to mixing the tubes 
for 2 minutes with a table vortex.  
 
20 
 
4.3 Removal of PCR inhibitors and the second sample clean-up 
 
The supernatants were moved into Inviadsorb tubes which bind the inhibitors in faeces 
efficiently [13]. After mixing and incubating at room temperature, the solids were pelleted 
to the bottom. After the centrifugation, supernatant was transferred into a 1.5 ml Eppen-
dorf and the centrifugation from the previous step repeated. Meanwhile, 25 µl of the pro-
teinase K was pipetted into a new set of 1.5 ml Eppendorf tubes. 
 
When transferring the supernatant from previous samples, it is important to not suspend 
the pellet by acting too hastily. It is also good to set the tubes in the centrifuge so that 
the pellet will appear on a certain side. When the stool is pelleted for the first time, it 
sometimes creates a sticky layer on top of the supernatant. This makes it more difficult 
to get the clear supernatant below it. This sticky substance often appears if there is too 
much solid particles in the samples. In some cases, the sticky substance would not pellet 
even after recentrifugation. 
 
Another factor that affects the difficulty of transferring the supernatant is the colour of the 
samples. The Inviadsorb tube is full of black powder. When the sample, that is dark-
brown, is added to the tube, the border between supernatant and the pellet becomes 
unclear. The suspension of the pellet with the supernatant can be avoided by placing the 
sample between a source of light or by pipetting the supernatant slowly. 
 
4.4 Proteinase K digestion 
 
The previous supernatant was transferred to the tubes containing the proteinase K. They 
were then thermomixed for 10 minutes. 
 
Some of the samples had less supernatant during this step than required. This is why 
it’s important to have enough of liquid sample in the beginning of the extractions. Since 
the samples were no longer inside safe locked tubes, they would often burst open or leak 
while being moved from the thermomixer to the laminar. The leaks were absorbed with 
paper and the bursting avoided by letting the samples stand for a minute or two before 
lifting them from the thermomixer.  
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4.5 Binding of the DNA 
 
After the digestion, the binding buffer was added and the mixture vortexed for 15 sec-
onds. The mixture was then transferred onto the spin filter in two batches, 700 µl batch 
and 300 µl batch. Both of the batches were incubated at room temperature for 2 minutes 
before centrifuging. 
 
The samples need to be vortexed separately to avoid any leakage. Even then it was 
important to keep the tube caps tightly closed with your hands since the samples were 
mixed with runny isopropanol. Although vortexing would be faster, it often causes a mess 
that needs to be cleaned afterwards. The mixture needs to be moved onto the spin filter 
in two batches since it can only contain 700 µl of sample by each centrifugation. 
 
4.6 Washing steps and ethanol removal 
 
When all the sample was bound to the filter membrane, the filter was first washed with 
washing buffer 1 and centrifuged. Receiver tube was changed and filter filled with wash-
ing buffer 2 and centrifuged. Receiver tube was emptied and re-used in ethanol removal. 
Ethanol was removed by centrifuging the sample at full speed for 4 minutes. Meanwhile 
the elution buffer was retrieved from the incubator. 
 
Both of the washing buffers are runny due to alcohol. This leads to dripping when pipet-
ting. Ethanol can dissolve the markings on the test tubes, thus you need to be careful 
when pipetting. Sometimes all the sample would not centrifuge properly on the filter. This 
might be due to solids clogging the filter. Eventually the liquid will get centrifuged but the 
DNA will not be as pure as it should.  
 
4.7 DNA elution 
 
Preheated elution buffer is added on the spin filter and incubated for 5 minutes. Mean-
while, an ice bath is prepared. After incubation, the samples are centrifuged into 1.5 ml 
receiver tube. After centrifugation, they are transferred to better tubes that are more ideal 
for longer times of freezing. The tubes are then put on ice and placed near the nanodrop 
machine. Samples are then measured with nanodrop and the results printed out. After 
22 
 
this, the laminar is and the used equipment are cleaned and the equipments moved back 
to their original places. 
5 DNA libraries of PD stool samples 
 
A protocol constructed by the DNA laboratory staff [Appendix 4 , Norppa-library protocol] 
was used, The process was done for the previously extracted 137 DNA samples. Alt-
hough most of the washing steps were done with a pipetting machine, Magnatrix, some 
were purified manually with the same reagents and protocol [Appendix 3, Clean up pro-
tocol]. 
 
5.1 Cutting the DNA with Bioruptor 
 
The sample DNA was added into Bioruptor tubes so that the concentration would be 1 
ug [DNA] / 100 µl [H2O]. The fragmented DNA was washed with Magnatrix or manually 
accordingly to the washing protocol [Appendix 3, Clean up protocol]. 
 
Magnatrix machinery is isolated by a plastic cover but it contains no air filtration system. 
The possibility for a contamination is, however, faint since the DNA is being purified in 
the process. 
 
5.2 End-repair, adapter ligation, PCR and size separation 
 
All the reagents that require thawing were thawed and placed on an ice bath. While the 
DNA was being purified, the master mix for end repair was prepared. The sample plate 
was moved on the ice bath and the required enzymes, T4 polynucleotide kinase, T4 DNA 
polymerase and DreamTaq polymerase were added to the cooled master-mix. Master-
mix was homogenized by pipetting and a portion of the mix was added to each of the 
wells containing the samples. The 96 well plate was moved into a PCR machine and an 
end repair program was performed accordingly to [Appendix 4, Norppa-library protocol]. 
When the program had finished, the samples were purified with Magnatrix or manually 
[Appendix 3, Clean up protocol]. 
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A master-mix containing the T4 DNA ligase buffer and the Y- adapter was prepared for 
the adapter ligation step and put on an ice bath. The samples were then placed on the 
ice bath and the enzyme T4 DNA ligase was added to the master-mix. Master-mix was 
then added to every well and the plate containing the samples was moved into a PCR 
machine. An adapter ligation program was used [Appendix 4, Norppa-library protocol]. 
After adapter ligation, another DNA purification step was performed with Magnatrix or 
manually [Appendix 3, Clean up protocol]. 
 
The primer indexes were pipetted individually to the bottom of the wells and a master-
mix containing MQ water, 5x phusion HF buffer, dNTP and PCR_Truseq_A was pre-
pared and placed on an ice bath. The Magnatrix plate was placed on the ice bath and 
the enzyme Phusion HotStart II was added to the master-mix. The samples were trans-
ferred to the wells containing the indexes, and the master-mix was added to these wells. 
The mixture was homogenized and divided so that each well would have 50 µl of sample 
in them. Samples were then vortexed and centrifuged briefly and moved into a PCR 
machine. A PCR program with 18 cycles was performed [Appendix 4, Norppa-library 
protocol]. After the run, the size separation program was performed with Magnatrix or 
manually [Appendix 2, DNA size separation step protocol]. 
 
Doing the washing steps manually has its’ problems. The manual aspect is a variable 
that creates variations between the samples. It would be more difficult to transfer the 
DNA into small strip tubes than it was to add the DNA into a Magnatrix well plate. 
 
6 Sequencing 
 
Preparing the Illumina sequencer is done accordingly to the protocol. This step reveals 
if there has been any mistakes during previous experiments. 
 
6.1 Pooling and purifying the samples and concentrating the pool 
 
The index labelled DNA samples were pooled together in an amount of 13.8 ng / sample. 
The total volume of the pool would be then ≈ 850 µl and the concentration ≈ 2.2 ng / µl. 
The pool would then be concentrated with a special filter column a few times, reducing 
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the volume to ≈ 20.0 µl and rising the concentration up to ≈ 67.0 ng / µl. A manual wash-
ing step was then performed two times, selecting the appropriate base size for the Illu-
minaNextSeq500. 
 
6.2 Sequencing the DNA library with IlluminaNextSeq500 
 
A part of the concentrated sample was pipetted and diluted. Part of this diluted sample 
was then pipetted into a new tube, which would then be optimized for the Illumina ma-
chine. After pooling the samples together, the optimized pool was transferred to a fully 
prepared Illumina reagent plate, the plate inserted into the Illumina machine and the se-
quencing program started. 
 
7 Results 
 
The result focus on the values measured from the DNA extractions and PCR products 
since they offer the best view on how the creation of the library succeeded. The Fragment 
Analyzer, AATI, report shows the quality of the DNA and the Illumina sequencing results 
the functioning of the DNA library. 
 
7.1 DNA extractions, nanodrop and values 
 
DNA extractions were done in a randomised order in a period of 16 days. The results are 
shown in table 1.  
 
Table 1. Concentrations, dates and sample names of all the DNA extractions in a chronological 
order 17.3 - 4.5.2015, excluding the repeated samples. Nanodrop measures the purity 
and amount of the DNA and Qubit measures the amount of the DNA. 
 
Sample ID 
Extraction date DNA µg / mL Nanodrop 
DNA µg / ml 
Qubit 
C_99 17.3.2015 169.71 56.1 
CS_119 17.3.2015 50.49 17.7 
CS_47 18.3.2015 22.54 5.48 
P_51 18.3.2015 8.72 3.51 
C_103 19.3.2015 664.73 120 
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PS_15 19.3.2015 5.49 2.79 
CS_73 20.3.2015 70.85 65.7 
C_137 20.3.2015 267.71 71.2 
P_60 20.3.2015 416.84 120 
C_69 20.3.2015 166.78 92.1 
P_119 23.3.2015 77.23 37.3 
C_95 23.3.2015 330.69 120 
P_58 23.3.2015 27.42 9.75 
CS_71 23.3.2015 139.51 19.8 
P_50 23.3.2015 159.37 92.5 
P_16 23.3.2015 43.6 21.7 
CS_114 23.3.2015 9.38 3.5 
CS_100 23.3.2015 118.12 35.2 
C_75 23.3.2015 91.11 45 
P_105 23.3.2015 64.8 43.4 
C_30 24.3.2015 24.19 12 
C_35 24.3.2015 266.32 99.6 
C_136 24.3.2015 12.2 3.5 
P_71 24.3.2015 21.4 9.58 
CS_107 24.3.2015 223.42 74 
C_102 24.3.2015 15.6 6.55 
C_74 24.3.2015 18.63 7.57 
C_116 24.3.2015 16.55 5.96 
P_77 24.3.2015 167.03 80.3 
CS_68 24.3.2015 227.27 92.1 
C_119 25.3.2015 1.31 0.3 
C_147 25.3.2015 117.49 36.6 
P_63 25.3.2015 121.63 52.7 
C_47 25.3.2015 64.31 35.8 
P_59 25.3.2015 35.05 14 
C_48 25.3.2015 235.65 94.4 
P_48 25.3.2015 102.76 51.1 
P_114 25.3.2015 105.83 52.5 
P_107 25.3.2015 25.24 14.4 
P_100 25.3.2015 41.44 9.44 
P_31 26.3.2015 170.96 76.4 
C_49 26.3.2015 404.21 120 
CS_65 26.3.2015 508.35 120 
C_23 26.3.2015 25.07 6.83 
C_8 26.3.2015 181.07 97.9 
C_86 26.3.2015 52 15.7 
C_90 26.3.2015 27.33 9.14 
C_80 26.3.2015 333.42 120 
C_96 26.3.2015 205.95 98.6 
P_53 26.3.2015 93.54 30.6 
P_61 27.3.2015 145.78 63.7 
P_57 27.3.2015 40.8 14.6 
P_42 27.3.2015 224.75 74.2 
P_69 27.3.2015 113.04 100 
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C_59 27.3.2015 68.31 32.2 
C_68 27.3.2015 190.95 40.9 
P_87 27.3.2015 66.32 22 
P_66 27.3.2015 24.32 19.1 
P_56 27.3.2015 166.85 62 
CS_41 27.3.2015 125.29 56.3 
P_126 27.3.2015 316.4 120 
P_68 27.3.2015 375.72 120 
C_146 27.3.2015 199.45 68.6 
C_118 27.3.2015 48.42 31 
P_65 27.3.2015 44.53 13.1 
P_99 30.3.2015 51.57 19.5 
P_79 30.3.2015 71.05 33.1 
CS_103 30.3.2015 179.22 63.8 
C_105 30.3.2015 78.3 47.1 
C_89 30.3.2015 79.6 84.1 
C_15 30.3.2015 239.94 97.5 
C_82 30.3.2015 127.37 43.1 
C_142 30.3.2015 6.46 2.7 
CS_87 30.3.2015 383.65 120 
C_135 30.3.2015 174.9 85.4 
P_94 30.3.2015 23.18 8.95 
P_120 30.3.2015 92.47 47.4 
P_83 30.3.2015 16.73 3.8 
P_47 30.3.2015 166.46 61 
P_8 30.3.2015 21.89 4.6 
C_19 31.3.2015 98.5 78.6 
C_88 31.3.2015 26.02 8.9 
C_33 31.3.2015 133.87 28.9 
C_104 31.3.2015 94.52 34.3 
CS_116 31.3.2015 39.26 11 
C_20 31.3.2015 36.86 14.7 
CS_66 31.3.2015 54.17 23.5 
C_65 31.3.2015 309.85 120 
P_88 31.3.2015 57.1 24.1 
CS_74 31.3.2015 45.08 18.6 
P_103 31.3.2015 94.65 35.5 
C_107 31.3.2015 152.93 56.3 
P_115 31.3.2015 366.96 120 
P_43 31.3.2015 54.08 19.9 
C_98 31.3.2015 12.9 1.9 
C_51 1.4.2015 67.62 16 
P_74 1.4.2015 68.69 20.8 
C_123 1.4.2015 423.33 120 
P_116 1.4.2015 198.26 96.4 
C_84_P 1.4.2015 20.23 5.89 
C_131_P 1.4.2015 505.06 120 
C_121_P 1.4.2015 44.58 14.2 
C_60_P 1.4.2015 591.64 120 
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C_10_P 1.4.2015 524.51 120 
P_21_P 1.4.2015 124.82 60.3 
P_104_II_P 1.4.2015 61.47 19.9 
C_115_P 1.4.2015 142.69 32.7 
C_125_II_P 1.4.2015 109.04 33.9 
C_152_II_P 1.4.2015 42.83 12 
C_109_P 1.4.2015 350.07 120 
C_8_P 2.4.2015 78.52 29.4 
C_127_P 2.4.2015 60.91 10.9 
P_62_P 2.4.2015 70.45 25.4 
C_56_P 2.4.2015 63.21 32 
C_93_P 2.4.2015 136.68 48.9 
P_110_P 2.4.2015 71.23 46.9 
C_99_II_P 2.4.2015 9.43 1.9 
C_106_P 2.4.2015 136.91 39.1 
CS_62 29.4.2015 315.6 120 
P_118 29.4.2015 251.9 94.1 
P_85 29.4.2015 57.68 100 
C_148 29.4.2015 487.7 120 
P_52 30.4.2015 350.51 120 
C_10 30.4.2015 86.4 120 
C_131 30.4.2015 27.64 68.5 
C_85 30.4.2015 31.87 56.2 
C_87 30.4.2015 344.08 120 
C_84 30.4.2015 79.46 110 
C_127 30.4.2015 8.72 42.8 
P_104 30.4.2015 39.34 22.4 
C_111 30.4.2015 140.96 99.1 
C_110 4.5.2015 316.72 120 
C_93 4.5.2015 139.4 120 
C_152 4.5.2015 626.01 120 
C_140 4.5.2015 103.99 46.7 
P_62 4.5.2015 388.02 120 
CS_31 4.5.2015 115.73 120 
 
DNA extractions were done in two batches. This was due to the samples arriving at dif-
ferent times to the laboratory. Figure 14 shows the amount of the samples processed 
each day and the time gap between the batches. 
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Figure 14. The amount of samples processed daily and the time between the two batches. The 
work was not continued during the weekends and had to be halted when waiting for 
more samples to arrive. Repeated samples excluded. 
 
From the raw values presented here, it is possible to evaluate the working process 
through the methods of standard variation. Since the samples were processed in two 
separate batches and were not randomised together, they are looked at separately. 
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Figure 15. Nanodrop values of the Batch 1 DNA extractions done chronologically. Y-axis shows 
the amount of DNA measured by the nanodrop and the X-axis shows the extraction 
order of the Batch 1 stool samples listed in Table 1. Repeated samples excluded. 
 
 
 
Figure 16. Qubit values of the Batch 1 DNA extractions done chronologically. Samples that were 
too high in DNA amount, are marked on the chart as 120 µg / ml. The Y-axis shows 
the amount of DNA measured by the Qubit and the X-axis shows the extraction order 
of the Batch 1 stool samples listed in Table 1. Repeated samples excluded. 
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The figures for Batch 1 show us that the experiments obey the standard variation as they 
should. The slight rise in Nanodrop values and the decrease in DNA amounts is not 
significant enough to suggest any worrying trends. If the trend lines would be steeper, 
you could say that the quality of the extracted samples are decreasing as the experi-
ments are executed. 
 
The second Batch was not as big as the first one. From the figures 17 and 18, it can be 
observed that the amount of DNA is greater in these samples. 
 
 
 
Figure 17. Nanodrop values of the Batch 2 DNA extractions done chronologically. Y-axis shows 
the amount of DNA measured by the nanodrop and the X-axis shows the extraction 
order of the stool samples listed in Table 1. Repeated samples excluded. 
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Figure 18. Qubit values of the Batch 2 DNA extractions done chronologically. Samples that were 
too high in DNA amount, were marked on the chart as 120 µg / ml. The Y-axis shows 
the amount of DNA measured with the Qubit and the X-axis shows the extraction order 
of the Batch 2 stool samples listed in Table 1. Repeated samples excluded. 
 
Similarly the extracted samples from Batch 2 show that the samples are standardly var-
iated and that the trend lines either rise or decrease slightly. From this we can conclude 
that the experiments were carried out in a similar manner and that the samples in Batch 
2 consisted of more DNA enriched samples than Batch 1. 
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Figure 19. Qubit values of the DNA extractions done chronologically. Samples that were too high 
in DNA amount, were marked on the chart as 120 µg / ml. The Y-axis shows the 
amount of DNA measured with the Qubit and the X-axis shows the extraction order of 
the stool samples listed in Table 1. Repeated samples excluded. 
 
If both of the batches were fitted into the same pictures, it would not be possible to ana-
lyse the laboratory work properly since the variances would not be accurate. Figure 19 
shows that randomising the samples prior to the tests is essential for analysing the work-
ing methods.  
 
7.2 DNA amount after PCR 
 
Table 1 shows the DNA yields of the extractions. Table 2 presents the DNA concentration 
values after the DNA samples had been processed with fragmentation, end-repair, 
adapter ligation, several washing steps, the adding of indexes, PCR and size separation. 
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Table 2. DNA amounts of PCR products of the PD stool samples in a chronological order. The 
table also shows in which method the washing steps were done during Bioruptor, end 
repair, adapter ligation and the PCR. The samples were processed from the largest 
amounts to the smallest amounts of starting DNA. High amounts of DNA are shown 
with green colours and low amounts are shown with red colours. 
 
Sample Index PCR Date 
DNA Concentration µg 
/ mL 
Washing Steps 
Done 
C_103 9.4.2015 4.95 Manually 
C_95 9.4.2015 3.90   
P_60 9.4.2015 4.99   
C_80 15.4.2015 9.99 Manually 
CS_65 15.4.2015 15.90   
C_49 15.4.2015 12.30   
P_68 15.4.2015 13.70   
CS_87 15.4.2015 11.40   
C_123 15.4.2015 9.67   
C_109_P 15.4.2015 10.50   
C_131_P 15.4.2015 8.30   
C_60_P 15.4.2015 7.55   
C_10_P 15.4.2015 8.17   
C_99 24.4.2015 4.84 Manually 
C_137 24.4.2015 7.10   
C_69 24.4.2015 10.60   
CS_73 24.4.2015 10.90   
C_75 24.4.2015 11.80   
CS_100 24.4.2015 13.60   
P_50 24.4.2015 11.40   
CS_68 24.4.2015 3.98   
CS_107 24.4.2015 3.30   
C_35 24.4.2015 4.17   
C_65 24.4.2015 3.94   
P_115 24.4.2015 4.83   
P_119 6.5.2015 3.37 Manually 
P_105 6.5.2015 5.92   
P_77 6.5.2015 7.06   
C_147 6.5.2015 6.47   
C_48 6.5.2015 3.87   
P_114 6.5.2015 4.11   
C_47 6.5.2015 3.71   
P_48 6.5.2015 6.45   
P_63 6.5.2015 4.01   
P_53 6.5.2015 3.91   
C_96 6.5.2015 5.17   
P_31 6.5.2015 5.16   
C_8 11.5.2015 1.87 Magnatrix 
P_61 11.5.2015 2.58   
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P_42 11.5.2015 1.97   
P_69 11.5.2015 3.49   
C_59 11.5.2015 3.14   
P_56 11.5.2015 3.12   
P_87 11.5.2015 2.33   
C_68 11.5.2015 2.06   
P_126 11.5.2015 3.18   
CS_41 11.5.2015 5.92   
C_118 11.5.2015 2.74   
C_146 11.5.2015 3.07   
P_120 18.5.2015 1.38 Magnatrix 
C_135 18.5.2015 2.57   
C_89 18.5.2015 1.14   
CS_103 18.5.2015 1.54   
C_105 18.5.2015 1.30   
P_79 18.5.2015 1.31   
P_47 18.5.2015 1.50   
C_15 18.5.2015 1.46   
C_33 18.5.2015 4.98   
C_107 18.5.2015 1.38   
P_103 18.5.2015 1.67   
P_88 21.5.2015 1.70 Magnatrix 
C_19 21.5.2015 1.74   
C_104 21.5.2015 2.28   
CS_66 21.5.2015 2.46   
P_74 21.5.2015 1.52   
P_116 21.5.2015 2.92   
C_125_II_P 21.5.2015 1.88   
C_115_P 21.5.2015 1.80   
P_21_P 21.5.2015 1.87   
C_106_P 21.5.2015 1.48   
P_110_P 21.5.2015 2.01   
C_93_P 21.5.2015 1.55   
CS_47 25.5.2015 1.63 Magnatrix 
P_58 25.5.2015 2.25   
C_116 25.5.2015 1.65   
C_102 25.5.2015 3.09   
C_74 25.5.2015 1.63   
P_71 25.5.2015 1.90   
P_100 25.5.2015 1.82   
C_86 25.5.2015 1.85   
C_90 25.5.2015 2.23   
P_62_P 25.5.2015 2.41   
C_8_P 25.5.2015 2.29   
C_56_P 25.5.2015 2.57   
C_23 27.5.2015 1.61 Magnatrix 
P_57 27.5.2015 3.21   
P_65 27.5.2015 2.25   
P_66 27.5.2015 1.95   
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P_94 27.5.2015 1.70   
P_99 27.5.2015 1.84   
CS_74 27.5.2015 2.40   
P_43 27.5.2015 1.48   
C_88 27.5.2015 2.06   
C_20 27.5.2015 2.33   
CS_116 27.5.2015 2.88   
C_51 27.5.2015 2.72   
C_148 1.6.2015 3.96 Magnatrix 
P_52 1.6.2015 1.13   
C_127 1.6.2015 1.65   
C_111 1.6.2015 1.14   
C_110 1.6.2015 1.52   
C_93 1.6.2015 2.44   
C_152 1.6.2015 1.31   
P_62 1.6.2015 1.47   
CS_31 1.6.2015 1.10   
C_82 1.6.2015 1.09   
C_152_II_P 3.6.2015 2.23 Magnatrix 
C_84_P 3.6.2015 2.15   
C_121_P 3.6.2015 2.30   
P_104_II_P 3.6.2015 2.16   
C_127_P 3.6.2015 2.30   
CS_62 3.6.2015 1.80   
P_118 3.6.2015 2.00   
P_85 3.6.2015 4.92   
C_10 3.6.2015 1.98   
C_131 3.6.2015 1.66   
C_87 3.6.2015 2.73   
C_84 3.6.2015 2.15   
P_8 11.6.2015 2.12 Magnatrix 
PS_15 11.6.2015 1.70   
CS_114 11.6.2015 1.78   
C_98 11.6.2015 5.94   
C_119 11.6.2015 3.83   
P_83 11.6.2015 8.41   
P_51 11.6.2015 2.51   
C_142 11.6.2015 1.40   
C_136 11.6.2015 2.38   
C_99_II_P 11.6.2015 2.67   
C_85 11.6.2015 2.23   
P_104 11.6.2015 1.90   
CS_119 15-16.6.2015 0.35 Magnatrix 
CS_71 15-16.6.2015 1.05   
P_16 15-16.6.2015 0.67   
C_30 15-16.6.2015 0.18   
P_107 15-16.6.2015 0.40   
P_59 15-16.6.2015 0.34   
C_140 17.6.2015 3.52 Manually 
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C_109_P 10.7.2015 3.26   
 
Most of the samples produced an sufficient amount of DNA during this step but some of 
them required additional PCR cycles. Although the order of execution was from the larg-
est to smallest amount of DNA, it seems that the samples which were processed with 
manual washing and size separation steps produced greater yields than the samples 
processed with a Magnatrix program.  
 
7.3 Fragment Analyzer 
 
The sample size was checked with Fragment Analyzer after every completed PCR pro-
gram. An ideal report has the fragment size centred near 400 base pairs. All of the Frag-
ment Analyzer results can be found in the appendix [Appendix 1, Fragment Analyzer 
figures]. An ideal report would look like the one depicted in Figure 20. 
 
 
 
Figure 20. Fragment Analyzer picture of the processed stool DNA sample C_87. The report 
shows the concentration of the sample and the size and amount of the DNA fragments. 
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Some of the samples ended up with a lower DNA concentration than others. These sam-
ples would have less DNA extracted during DNA extractions and would produce eventu-
ally less reads than others. Figure 21 shows one of these samples after the size sepa-
ration. 
 
 
 
Figure 21. Fragment Analyzer picture of the processed stool DNA sample C_30. The report 
shows the concentration of the sample and the size and amount of the DNA fragments. 
 
Most of the figures produced by Fragment Analyzer were good and within the expected 
fragment size. Some of the samples had a concentration that was below the average, 
but even they were all successfully sequenced with the Illumina sequencing machine. 
The difficult samples were P_16, C_30, P_59, P_107 and CS_119. 
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7.4 Sequencing quality 
 
Sequencing results can be evaluated by using a sequencing quality control software 
such as FastQC. By looking at the pictures and comparing them with the ideal control 
pictures, we can determine how successful the sequencing was. The per base sequence 
quality pictures and per tile sequence quality pictures were chosen to represent the Illu-
mina results. 
 
 
 
Figure 22.  Ideal Fast QC report for a sample sequenced on the Illumina nextseq 500 platform. 
Per tile sequence quality shows the results in tile colours from blue to red. The redder 
the tile is, the worse the quality of that base in comparison with the other tiles. Per 
base sequence quality shows the overview of the range of quality in the same posi-
tions as the per tile sequence quality picture. Information on Fast QC reports can be 
found in [45]. 
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Figure 23. Illumina Fast QC per tile sequence quality and per base sequence quality report for 
the forward reads of the pooled stool DNA samples. 
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Figure 24. Illumina fast QC per tile sequence quality and per base sequence quality report for the 
reverse reads of the pooled stool DNA sample. 
 
From these reports we can conclude that the quality of the reads was not as good as it 
should have been. Especially the tile qualities are far from optimal. 
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Figure 25. All of the reads produced by the DNA library. One dot represents the amount of reads 
produced by one sample. The closer to the trend line the dot is, the more evenly it has 
produced reads in comparison with the other samples. Undetermined fragments were 
excluded from the figure. They produced 31 457 834 reads which is 4 % from the total. 
 
By looking at Figure 25, we can see that some of the samples produced more reads than 
the others. This can be due to uneven amounts of DNA in the pool sample or due to 
reads with poor quality. On the basis of the Fast QC reports for the forward and reverse 
reads, the latter would seem more probable. This could have been caused by inserting 
too much of the sample inside the machine. 
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8 Conclusions 
 
The goal of the thesis was to create a DNA metagenomics library for the 138 PD stool 
samples and to provide a view on how it could be done. Although DNA could not be 
extracted from one of the samples, the majority of the samples were successfully se-
quenced with the Illumina platform. Since the amount of DNA did not correlate with the 
time parameter in either of the batches, the extractions can be reviewed as trustworthy. 
The quality of the sequence reads was not optimal. Both these measurements, however, 
show that the creation of the DNA library was a success, although the sequencing could 
have succeeded better. 
 
The practical side of the project was a success and there was plenty of useful information 
in other articles to help in understanding the library preparation process better. Some 
improvements could be made to the DNA plus kit protocol. At the moment, only the first 
thermomixer step is done with safe lock tubes. The second thermomixing causes the 
tubes to pop open randomly. This could lead to cross contamination. After the thesis, 
Harri Kangas had noticed that the product size from the Bioruptor step seemed to be 
smaller than it should have. This led to the small fragmented DNA to be washed away in 
the first washing step, reducing the DNA concentration. This observation was made 
when the DNA amount was reduced too much during the whole process. The program-
ming for the Bioruptor is being optimized for the next experiments. 
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Appendix 1 
 
Fragment Analyzer figures  
 
 
 
Figure 26. Fragment Analyzer figures for 35 samples compressed into one picture April 27th. The 
pictures show the amounts and overall distributions of different sized DNA fragments 
within the samples. 400 bp was the wanted size.  
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Figure 27. Fragment Analyzer figures for 35 samples compressed into one picture May 8th - May 
28th. The pictures show the amounts and overall distributions of different sized DNA 
fragments within the samples. 400 bp was the wanted size. 
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Figure 28. Fragment Analyzer figures for 35 samples compressed into one picture May 28th - 
June 5th. The pictures show the amounts and overall distributions of different sized 
DNA fragments within the samples. 400 bp was the wanted size. 
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Figure 29. Fragment Analyzer figures for 33 samples compressed into one picture June 23rd. The 
pictures show the amounts and overall distributions of different sized DNA fragments 
within the samples. 400 bp was the wanted size 
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Figure 30. Fragment Analyzer figures for the controls April 27th - June 23rd. 
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Appendix 2 
The size separation step protocol 
 
 
 
Protocol 1. Size separation and washing protocol for the PD stool sample DNA. 
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Appendix 3 
Clean up protocol. 
 
 
 
Protocol 2. Washing step protocol for the PD stool sample DNA. 
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Appendix 4 
Norppa PCR protocol for NGS library 
 
 
 
Protocol 3. Norppa PCR protocol for the PD stool sample DNA. 
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Appendix 5 
PSP spin stool DNA plus kit protocol 
 
 
 
Protocol 4. PSP spin stool DNA plus kit protocol scheme used for the extractions of the PD stool 
samples 
